Darbepoetin Alfa Effectively Maintains Haemoglobin Concentrations at Extended Dose Intervals Relative to Intravenous or Subcutaneous Recombinant Human Erythropoietin in Dialysis Patients

Nephrology Dialysis Transplantation - United Kingdom
doi 10.1093/ndt/gfh106
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Oxford University Press (OUP)

Related search

Beneficial Effect of High Dose Darbepoetin-Alfa in Peritoneal Dialysis Patients With Renal Anemia

Nihon Toseki Igakkai Zasshi
2010English

Single-Dose Intravenous Administration of Recombinant Human Erythropoietin Is a Promising Treatment for Patients With Acute Myocardial Infarction

Circulation Journal
MedicineCardiovascular MedicineCardiology
2010English

Response of Anaemia in Rheumatoid Arthritis to Treatment With Subcutaneous Recombinant Human Erythropoietin.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1992English

Bioequivalence of HX575 (Recombinant Human Epoetin Alfa) and a Comparator Epoetin Alfa After Multiple Subcutaneous Administrations

Pharmacology
MedicinePharmacology
2008English

The Influence of Formula Concentration on the Absorption of Darbepoetin Alfa After Subcutaneous Administration

Journal of Bioequivalence & Bioavailability
2010English

Selective Use of Recombinant Human Erythropoietin in Pregnant Patients With Severe Anemia or Nonresponsive to Iron Sucrose Alone

Fetal Diagnosis and Therapy
Nuclear MedicineRadiologyChild HealthGynecologyPerinatologyImagingObstetricsMedicinePediatricsEmbryology
2009English

Darbepoetin Versus Epoetin Alfa for the Correction of Anemia in Cancer Patients Receiving Radiotherapy or Chemoradiotherapy Treatment

Clinical medicine. Oncology
2008English

Intravenous Ascorbic Acid as an Adjuvant Therapy for Recombinant Erythropoietin in Hemodialysis Patients With Hyperferritinemia

Kidney International
Nephrology
1999English

Use of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Immunoglobulin in Elderly Patients

Immunotherapy
OncologyAllergyImmunology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy